Geoffrey Banda
Biographic Data
| ID | 5990781 |
|---|---|
| NAME | Geoffrey Banda |
| GIVEN NAMES | Geoffrey |
| FAMILY NAME | Banda |
| SIGNATURE | BANDA G |
| AFFILIATIONS | University of Edinburgh |
| ORCID | 0000-0002-0194-3620 |
| VERIFIED | Yes |
| TOTAL WORKS | 8 |
| TOTAL CITATIONS | 5 |
| WORKS AS AUTHOR | 8 |
| WORKS AS EDITOR | 0 |
| FIRST PUBLICATION YEAR | 2015 |
| LATEST PUBLICATION YEAR | 2023 |
| H-INDEX | 1 |
What does equitable global health research and delivery look like? Tackling Infections to Benefit Africa (Tiba) partnership as a case study
There is a current global push to identify and implement best practice for delivering maximum impact from development research in low-income and middle-income countries. Here, we describe a model of research and capacity building that challenges traditional approaches taken by western funders in Africa. Tackling Infections to Benefit Africa (TIBA) is a global health research and delivery partnership with a focus on strengthening health systems to…
Introduction
Background African countries face multiple developmental, economic, social and industrial transformation hurdles, especially in the era of sustainable development and sensitivity to environmental damage. As late-comer industrialisers, there is some catching up to do, but they need to navigate complex, international, legal and institutional agreements that early industrialisers did not face. Given the environmental concerns, it is not surprising t…
Optimising governance capabilities for science, research and innovation in Africa
Local manufacturing, local supply chains and health security in Africa
African commentators have long emphasised the importance of local manufacturing for local health security, but the argument has struggled to gain an international hearing. \n \nCOVID-19 has, however, demonstrated the health dangers from extreme import dependence and low purchasing power; it has also shown the scope and capability for local industrial innovation. \n \nLocal innovation and manufacturing scale-up during the pandemic was facilitated …
Oxygen provision to fight Covid-19 in sub-Saharan Africa
The adequate provision of medical oxygen is going to make the difference between life and death for the majority of patients with COVID-19 in Africa. Sub-Saharan African countries lack affordable and reliable oxygen supply. There is evidence from sub-Saharan Africa for why medical oxygen provision must be made a regional urgent priority. Efforts being made in some African countries demonstrate how oxygen provision can be scaled up through innovat…
Strengthening national health research systems in the WHO African Region – progress towards universal health coverage
BACKGROUND: Health challenges and health systems set-ups differ, warranting contextualised healthcare interventions to move towards universal health coverage. As such, there is emphasis on generation of contextualized evidence to solve local challenges. However, weak research capacity and inadequate resources remain an impendiment to quality research in the African region. WHO African Region (WHO AFR) facilitated the adoption of a regional strate…
Health-industry linkages for local health
The benefits of local production of pharmaceuticals in Africa for local access to medicines and to effective treatment remain contested. There is scepticism among health systems experts internationally that production of pharmaceuticals in sub-Saharan Africa (SSA) can provide competitive prices, quality and reliability of supply. Meanwhile low-income African populations continue to suffer poor access to a broad range of medicines, despite major i…
Re-Thinking Pharmaceutical Production in Africa; Insights from the Analysis of the Local Manufacturing Dynamics in Mozambique and Zimbabwe
Re-Thinking Pharmaceutical Production in Africa; Insights from the Analysis of the Local Manufacturing Dynamics in Mozambique and Zimbabwe
Optimising governance capabilities for science, research and innovation in Africa
Health-industry linkages for local health
The benefits of local production of pharmaceuticals in Africa for local access to medicines and to effective treatment remain contested. There is scepticism among health systems experts internationally that production of pharmaceuticals in sub-Saharan Africa (SSA) can provide competitive prices, quality and reliability of supply. Meanwhile low-income African populations continue to suffer poor access to a broad range of medicines, despite major i…
Re-Thinking Pharmaceutical Production in Africa; Insights from the Analysis of the Local Manufacturing Dynamics in Mozambique and Zimbabwe
Health-industry linkages for local health
The benefits of local production of pharmaceuticals in Africa for local access to medicines and to effective treatment remain contested. There is scepticism among health systems experts internationally that production of pharmaceuticals in sub-Saharan Africa (SSA) can provide competitive prices, quality and reliability of supply. Meanwhile low-income African populations continue to suffer poor access to a broad range of medicines, despite major i…
Strengthening national health research systems in the WHO African Region – progress towards universal health coverage
BACKGROUND: Health challenges and health systems set-ups differ, warranting contextualised healthcare interventions to move towards universal health coverage. As such, there is emphasis on generation of contextualized evidence to solve local challenges. However, weak research capacity and inadequate resources remain an impendiment to quality research in the African region. WHO African Region (WHO AFR) facilitated the adoption of a regional strate…
Oxygen provision to fight Covid-19 in sub-Saharan Africa
The adequate provision of medical oxygen is going to make the difference between life and death for the majority of patients with COVID-19 in Africa. Sub-Saharan African countries lack affordable and reliable oxygen supply. There is evidence from sub-Saharan Africa for why medical oxygen provision must be made a regional urgent priority. Efforts being made in some African countries demonstrate how oxygen provision can be scaled up through innovat…
Local manufacturing, local supply chains and health security in Africa
African commentators have long emphasised the importance of local manufacturing for local health security, but the argument has struggled to gain an international hearing. \n \nCOVID-19 has, however, demonstrated the health dangers from extreme import dependence and low purchasing power; it has also shown the scope and capability for local industrial innovation. \n \nLocal innovation and manufacturing scale-up during the pandemic was facilitated …
Introduction
Background African countries face multiple developmental, economic, social and industrial transformation hurdles, especially in the era of sustainable development and sensitivity to environmental damage. As late-comer industrialisers, there is some catching up to do, but they need to navigate complex, international, legal and institutional agreements that early industrialisers did not face. Given the environmental concerns, it is not surprising t…
Optimising governance capabilities for science, research and innovation in Africa
What does equitable global health research and delivery look like? Tackling Infections to Benefit Africa (Tiba) partnership as a case study
There is a current global push to identify and implement best practice for delivering maximum impact from development research in low-income and middle-income countries. Here, we describe a model of research and capacity building that challenges traditional approaches taken by western funders in Africa. Tackling Infections to Benefit Africa (TIBA) is a global health research and delivery partnership with a focus on strengthening health systems to…
Economic growth (7 works) · Economics (7 works) · Political science (6 works) · Business (5 works) · Health care (4 works) · Medicine (4 works) · Global Health and Surgery (3 works) · Global Maternal and Child Health (3 works) · Sociology (3 works) · Corporate governance (2 works)